Bxp expands life sciences portfolio in kendall square in cambridge, ma

Boston--(business wire)--bxp (nyse: bxp), the largest publicly traded developer, owner, and manager of premier workplaces in the united states, announced today that it completed the acquisition of 125 broadway, a six-story, 271,000 square foot laboratory/life sciences property. bxp purchased the property from biogen for a gross purchase price of approximately $592.0 million. biogen has signed a lease for and will continue to occupy the entire property through april 2028. bxp funded the purchase
BXP Ratings Summary
BXP Quant Ranking